ArticleNature immunology2011

Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF).

Dongxu Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.